Mar112020UncategorizedCategory: UncategorizedBy Charlotte Maddalena11 March 2020Leave a comment Author: Charlotte Maddalena Post navigationPreviousPrevious post:First patient treated with anti-CD39 mAb IPH5201 on OREGA’s 10-year anniversary dayNextNext post:Three new projects supported by our FoundationRelated PostsNewsletter July 20206 July 2020Alizé Pharma 3 Announces Rebranding to Amolyt Pharma4 June 2020Nine new projects supported by our Foundation14 May 2020ORPHELIA Pharma recrute un/une Chargé Assurance Qualité20 April 2020Newsletter april 202019 April 2020Three new projects supported by our Foundation20 March 2020
